Acetrizoic Acid
An iodinated contrast medium used in older radiological imaging to enhance the visibility of internal structures on X-ray examinations. Like other early ionic contrast agents, it carries a higher risk of allergic reactions and discomfort compared to modern low-osmolality contrast agents. It is primarily of historical interest in the development of diagnostic radiology.
Moleküler Ağırlık
556,8600 g/mol
LogP
2,60
TPSA
66,40 Ų
Lipinski RO5
Geçer
Etki Mekanizması
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
2D Yapı
Cite this structure
Embed this structure
SMILES
CC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I
InChI
InChI=1S/C9H6I3NO3/c1-3(14)13-8-5(11)2-4(10)6(7(8)12)9(15)16/h2H,1H3,(H,13,14)(H,15,16)
Molecular Formula
C9H6I3NO3
HBD / HBA
2 / 3
Döndürülebilir Bağlar
2
Ağır Atomlar
16
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
An iodinated contrast medium used in older radiological imaging to enhance the visibility of internal structures on X-ray examinations. Like other early ionic contrast agents, it carries a higher risk of allergic reactions and discomfort compared to modern low-osmolality contrast agents. It is primarily of historical interest in the development of diagnostic radiology.
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Yes, Acetrizoic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201327. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 6806. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="acetrizoic-acid"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/acetrizoic-acid/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/acetrizoic-acid/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/acetrizoic-acid/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="acetrizoic-acid"></drugfyi-drug>